259 related articles for article (PubMed ID: 8403741)
1. Cefepime clinical pharmacokinetics.
Okamoto MP; Nakahiro RK; Chin A; Bedikian A
Clin Pharmacokinet; 1993 Aug; 25(2):88-102. PubMed ID: 8403741
[TBL] [Abstract][Full Text] [Related]
2. Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Barradell LB; Bryson HM
Drugs; 1994 Mar; 47(3):471-505. PubMed ID: 7514976
[TBL] [Abstract][Full Text] [Related]
3. Cefepime: a new fourth-generation cephalosporin.
Okamoto MP; Nakahiro RK; Chin A; Bedikian A; Gill MA
Am J Hosp Pharm; 1994 Feb; 51(4):463-77; quiz 541-2. PubMed ID: 8017411
[TBL] [Abstract][Full Text] [Related]
4. Cefepime: a fourth-generation parenteral cephalosporin.
Wynd MA; Paladino JA
Ann Pharmacother; 1996 Dec; 30(12):1414-24. PubMed ID: 8968455
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections.
Holloway WJ; Palmer D
Am J Med; 1996 Jun; 100(6A):52S-59S. PubMed ID: 8678098
[TBL] [Abstract][Full Text] [Related]
7. Cefepime.
Cunha BA; Gill MV
Med Clin North Am; 1995 Jul; 79(4):721-32. PubMed ID: 7791419
[TBL] [Abstract][Full Text] [Related]
8. Cefepime microbiologic profile and update.
Kessler RE
Pediatr Infect Dis J; 2001 Mar; 20(3):331-6. PubMed ID: 11303846
[TBL] [Abstract][Full Text] [Related]
9. Low-dosage cefepime as treatment for serious bacterial infections.
Giamarellou H
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():123-32. PubMed ID: 8150755
[TBL] [Abstract][Full Text] [Related]
10. Ceftibuten pharmacokinetics and pharmacodynamics. Focus on paediatric use.
Kearns GL; Young RA
Clin Pharmacokinet; 1994 Mar; 26(3):169-89. PubMed ID: 8194281
[TBL] [Abstract][Full Text] [Related]
11. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
12. Cefepime as treatment for osteomyelitis and other severe bacterial infections.
Jauregui L; Matzke D; Scott M; Minns P; Hageage G
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():141-9. PubMed ID: 8150758
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetic profile of a new generation of parenteral cephalosporin.
Rybak M
Am J Med; 1996 Jun; 100(6A):39S-44S. PubMed ID: 8678096
[TBL] [Abstract][Full Text] [Related]
14. A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infections.
Mouton Y; Chidiac C; Humbert G; Leroy J; Veyssier P; Modai J; Bertrand A; Dellamonica P; Micoud M; Stahl JP
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():133-40. PubMed ID: 8150757
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.
Bijie H; Kulpradist S; Manalaysay M; Soebandrio A
J Chemother; 2005 Feb; 17(1):3-24. PubMed ID: 15828439
[TBL] [Abstract][Full Text] [Related]
16. Fourth generation cephalosporins in the antimicrobial chemotherapy of surgical infections.
Giamarellou H
J Chemother; 1999 Dec; 11(6):486-93. PubMed ID: 10678790
[TBL] [Abstract][Full Text] [Related]
17. Third-generation cephalosporins: a critical evaluation.
Barriere SL; Flaherty JF
Clin Pharm; 1984; 3(4):351-73. PubMed ID: 6432420
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
19. Cefepime: a reappraisal in an era of increasing antimicrobial resistance.
Endimiani A; Perez F; Bonomo RA
Expert Rev Anti Infect Ther; 2008 Dec; 6(6):805-24. PubMed ID: 19053894
[TBL] [Abstract][Full Text] [Related]
20. Cefepime.
Hardin TC; Jennings TS
Pharmacotherapy; 1994; 14(6):657-68. PubMed ID: 7885968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
